BB 13: Blood and Blood Components (Pt. 1)

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/92

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 4:33 PM on 7/12/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

93 Terms

1
New cards

volume variations and quantity of cellular elements are large for _____.

apheresis

2
New cards

WB must be collected within ____ minutes.

15-20

3
New cards

platelets are stored at _____°C.

20-24°C

4
New cards

plasma are stored at _____°C.

1-6°C

5
New cards

platelets and plasma components must be created within ____ hours from initial collection time.

8

6
New cards

CPD, CP2D, and ACD additives have a ____ day expiration.

21

7
New cards

CPDA-1 has a ____ day expiration.

35

8
New cards

additive solutions (e.g., AS-1, AS-3, AS-5) have a ____ day expiration.

42

9
New cards

it is against the law to use any blood/blood product past its expiration date. true or false?

true

10
New cards

it is against the law to use any blood/blood product that exceeds any of the applicable temperature ranges. true or false?

true

11
New cards

____ storage lesion biochemical changes involve:

  • decreased glucose

  • decreased ATP (causes increased Hb O2 affinity)

  • decreased 2,3 DPG declines rapidly after 1-2 weeks (causes increased Hb O2 affinity)

  • decreased pH

RBC

12
New cards

____ storage lesion biochemical changes involve:

  • increased K+ in supernatant

  • increased free Hb

RBC

13
New cards

____ storage lesion morphological changes involve:

  • irreversible shape deformity

  • increased osmotic fragility

RBC

14
New cards

____ storage lesion biochemical changes involve:

  • decreased glucose

  • decreased pH

  • increased LDH

platelet

15
New cards

____ storage lesion morphological changes involve:

  • very fragile/fragmentation; degranulation occurs

  • without continuous rotation, PLTs will clump

  • irreversible shape deformity from discoid to spherical

  • decreased in-vivo recovery, survival, and function

platelet

16
New cards

____ storage lesion biochemical changes involve:

  • deterioration of heat liable coagulation factors

    • e.g., factor V and VIII

plasma

17
New cards

____ storage lesion morphological changes involve:

  • there are no cellular elements found in plasma products

    • there is no morphological changes occurring

plasma

18
New cards

the life span of RBCs in the body are ____ days.

120

19
New cards

the life span of platelets in the body are ____ days.

10

20
New cards

the life span of WBCs in the body are ____ days.

1-3

21
New cards

the ____ blood label is used on all blood products.

ISBT

22
New cards

____ indications include:

  • acute hemorrhaging

    • trauma or massive bleed

  • volume replacement

    • hypovolemia

  • increase oxygen carrying capacity to vital organs

    • e.g., brain, liver, heart, kidneys, etc.

WB

23
New cards

the storage temperature for whole blood is ____°C.

1-6°C

24
New cards

the expiration of whole blood with ACD, CPD, or CP2D is ____ days.

21

25
New cards

the transport temperature of whole blood is _____°C.

1-10°C

26
New cards

the use of _____ as the resuscitation product of choice for the treatment of hemorrhagic shock for all casualties has been endorsed by the Joint Trauma System, the Defense Committee on Trauma, and the Armed Services Blood Program.

LTOWB

27
New cards

the storage temperature for LTOWB is ____°C.

1-6°C

28
New cards

the expiration for LTOWB for ACD, CPD, or CP2D is ____ days.

21

29
New cards

the transport temperature for LTOWB is ____°C.

1-10°C

30
New cards

A and B hemagglutination titer is ____ for LTOWB.

< 1:256

31
New cards

some BBs only use LTOWB for ____ days and afterwards the unit is spun down, plasma removed and discarded, the RBCs are retained with expiration date as appropriate to anticoagulant preserve.

14

32
New cards

when _____ is given to a patient PRIOR to hospital admission, the patient has a high probability of being mistyped due to transfused blood.

LTOWB

33
New cards

the storage temperature of leuko-reduced (LR) WB is ____°C.

1-6°C

34
New cards

the expiration of leuko-reduced (LR) WB for CPD or CP2D is ____ days.

21

35
New cards

the expiration of leuko-reduced (LR) WB for CPDA-1 is ____ days.

35

36
New cards

QC requirements of leuko-reduced (LR) WB include _____ WBCs and >85% RBC recovery in at least 95% of the units tested.

<5 × 106

37
New cards

usually a ____ WB collection is somewhere between 300 to 404 mLs for a 450mL collection or 333 to 449 mLs for a 500 mL collection.

low volume

38
New cards

only ____ can be made and labeled as low volume.

RBCs

39
New cards

plasma and platelets from low volume units should be discarded. true or false?

true

40
New cards

RBCs in ACD, CPD, or CP2D have a ____ day expiration.

21

41
New cards

RBCs with an additive solution (e.g., Adsol, Nutricel, Optisol) have a ____ day expiration.

42

42
New cards

RBCs in CPDA-1 have a ____ day expiration.

35

43
New cards

leukoreduced RBCs have a ____ day expiration.

42

44
New cards

____% of blood transfusions use RBCs.

98%

45
New cards

____ unit of RBCs raises hemoglobin ____g/dL.

1

46
New cards

____ unit of RBCs raises HCT ~3%.

1

47
New cards

the following are indications for which blood product:

  • anemia condition

  • less volume to help prevent hyppervolemia

  • increased oxygen carrying capacity to vital organs

RBCs

48
New cards

the QC requirements for RBC HCT is ____% for a non additive RBC product.

<80%

49
New cards

additive must be added to RBCs within ____ days of collection when temperature is maintained at 1-6°C.

3

50
New cards

what blood product helps reduce febrile transfusion reactions and TRALI due to lack/reduced number of WBCs and platelets in the product?

LR-RBCs

51
New cards

what is the storage temperature LR-RBCs?

1-6°C

52
New cards

what is the expiration of LR-RBCs in days?

42

53
New cards

what is the transport temperature LR-RBCs?

1-10°C

54
New cards

____ contain RBCs and additive solution with essentially no WBCs or PLTs.

LR-RBCs

55
New cards

for LR-RBCs, _____ WBCs in at least 95% of units tested in required for QC.

<5 × 106

56
New cards

for LR-RBCs, _____% RBC recovery in at least 95% of units tested in required for QC.

>85%

57
New cards

what blood product removes plasma proteins (IgA, IgG, etc.) during washing cycles?

W-RBCs

58
New cards

what blood product removes other accumulated substances present in stored blood (e.g., K+)?

W-RBCs

59
New cards

what is the storage temperature of W-RBCs?

1-6°C

60
New cards

what is the expiration of W-RBCs (open system process)?

24 hours

61
New cards

what is the transport temperature of W-RBCs?

1-10°C

62
New cards

what blood product contains RBCs and saline?

W-RBCs

63
New cards

_____ means the hermetic seal on the original blood bag is broken to gain access into the product.

open system

64
New cards

once the hermetic seal is broken, the expiration date changes from the original outdate to ____.

24 hours

65
New cards

rare phenotypes are ____ for future transfusions (e.g., hr'“ negative, Oh, U negative, etc.).

frozen

66
New cards

autologous blood is often _____.

frozen

67
New cards

high glycerol (____%) is most commonly used in the USA.

40%

68
New cards

low glycerol refers to ____%.

15-20%

69
New cards

F-RBCs must be frozen within ____ days from collection.

6

70
New cards

the storage temperature of _____ F-RBCs is <65°C in a mechanical BB ultra low freezer (usually at -80°C).

high glycerol

71
New cards

the storage temperature of _____ F-RBCs is <165°C in liquid nitrogen vapor OR <196°C in liquid nitrogen in a monitored liquid nitrogen tank.

low glycerol

72
New cards

what is the expiration for F-RBCs?

10 years

73
New cards

the transport temperature for ____ F-RBCs is dry ice.

high glycerol

74
New cards

the transport temperature for ____ F-RBCs is liquid N2.

low glycerol

75
New cards

prior to the transfusion of F-RBCs, removal of all cryoprotective agent is performed using varying dilutions of saline with dextrose in a process called ____.

deglycerolization

76
New cards

in the USA, F-RBCs must rapidly thaw in a ____°C waterbath before removing the cryoprotective agent.

37°C

77
New cards

thawed and processed F-RBCs are called ____ product.

deglycerolized RBCs

78
New cards

what is the storage temperature for deglycerolized RBCs?

1-6°C

79
New cards

what is the expiration for deglycerolized RBCs (open system process)?

24 hours

80
New cards

what is the transport temperature for deglycerolized RBCs?

1-10°C

81
New cards

what blood product contains RBCs and 0.9% saline with 0.2% dextrose?

deglycerolized RBCs

82
New cards

____ products are made from a whole blood collection using a 2-step differential centrifugation process (low RPM then high RPM).

platelet

83
New cards

what product is used to treat or prevent bleeding from thrombocytopenia and/or platelet functional disorders?

platelet concentrate

84
New cards

platelet concentrate product can raise platelet counts to _____/uL in a 70kg adult.

5000

85
New cards

what is the storage temperature of platelet concentrate?

20-24°C

86
New cards

platelet concentrate requires constant agitation. true or false?

true

87
New cards

what is the expiration of platelet concentrate?

5 days

88
New cards

what is the expiration of platelet concentrate with performance of bacterial detection testing?

7 days

89
New cards

what is the transport temperature of platelet concentrate?

20-24°C

90
New cards

the QC of platelet concentrate is ____ platelets.

>5.5 × 1010

91
New cards

the QC of platelet concentrate is a pH of ____..

>6.2

92
New cards

what is the expiration of platelet concentrate pooled?

4 hours

93
New cards

the QC requirements of LR-platelet concentrate is ____ WBCs in 95% of the units tested.

<8.3 × 105